The latest twist in a long-running dispute between the drug industry and insurers over which group is more to blame for rising costs to patients. And patients are, again, caught in the middle.
Tens of thousands of employers who buy insurance coverage for their workers will get this more-complete pricing picture — and may not like what they see.